Europe Antibiotics Market Forecast to 2027 - By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Antibiotics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Antibiotics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increase in bacterial infections
5.1.2 Growing demand for generic antibiotics

5.2 Market Opportunities

5.2.1 Expansion in emerging economies
5.2.2 Growth in antibiotic resistance research

5.3 Future Trends

5.3.1 Development of next-generation antibiotics
5.3.2 Rise in the adoption of combination therapies

5.4 Impact of Drivers and Restraints

6. Europe Antibiotics Market Regional Analysis

6.1 Europe Antibiotics Market Overview

6.2 Europe Antibiotics Market Revenue 2017-2027 (US$ Million)

6.3 Europe Antibiotics Market Forecast Analysis

7. Europe Antibiotics Market Analysis – by Drug Class

7.1 Sulfonamides

7.1.1 Overview
7.1.2 Sulfonamides: Europe Antibiotics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Aminoglycosides

7.2.1 Overview
7.2.2 Aminoglycosides: Europe Antibiotics Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Carbapenem

7.3.1 Overview
7.3.2 Carbapenem: Europe Antibiotics Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Macrolides

7.4.1 Overview
7.4.2 Macrolides: Europe Antibiotics Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Fluoroquinolones

7.5.1 Overview
7.5.2 Fluoroquinolones: Europe Antibiotics Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Penicillin

7.6.1 Overview
7.6.2 Penicillin: Europe Antibiotics Market – Revenue and Forecast to 2031 (US$ Million)

7.7 Cephalosporin

7.7.1 Overview
7.7.2 Cephalosporin: Europe Antibiotics Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Antibiotics Market Analysis – by Action Mechanism

8.1 Mycolic Acid Inhibitors

8.1.1 Overview
8.1.2 Mycolic Acid Inhibitors: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

8.2 RNA Synthesis Inhibitors

8.2.1 Overview
8.2.2 RNA Synthesis Inhibitors: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

8.3 DNA Synthesis Inhibitors

8.3.1 Overview
8.3.2 DNA Synthesis Inhibitors: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Protein Synthesis Inhibitors

8.4.1 Overview
8.4.2 Protein Synthesis Inhibitors: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

8.5 Cell Wall Synthesis Inhibitors

8.5.1 Overview
8.5.2 Cell Wall Synthesis Inhibitors: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Antibiotics Market – Europe Analysis

9.1 Europe

9.1.1 Europe Antibiotics Market Breakdown, by Key Country, 2020 and 2027 (%)
9.1.1.1 Europe Antibiotics Market – Revenue and Forecast Analysis – by Country
9.1.1.1 UK: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.1.1 UK: Europe Antibiotics Market Breakdown, by Drug Class
9.1.1.1.2 UK: Europe Antibiotics Market Breakdown, by Action Mechanism

9.1.1.2 Germany: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.2.1 Germany: Europe Antibiotics Market Breakdown, by Drug Class
9.1.1.2.2 Germany: Europe Antibiotics Market Breakdown, by Action Mechanism

9.1.1.3 France: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.3.1 France: Europe Antibiotics Market Breakdown, by Drug Class
9.1.1.3.2 France: Europe Antibiotics Market Breakdown, by Action Mechanism

9.1.1.4 Russia: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.4.1 Russia: Europe Antibiotics Market Breakdown, by Drug Class
9.1.1.4.2 Russia: Europe Antibiotics Market Breakdown, by Action Mechanism

9.1.1.5 Italy: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.5.1 Italy: Europe Antibiotics Market Breakdown, by Drug Class
9.1.1.5.2 Italy: Europe Antibiotics Market Breakdown, by Action Mechanism

9.1.1.6 Rest of Europe: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.6.1 Rest of Europe: Europe Antibiotics Market Breakdown, by Drug Class
9.1.1.6.2 Rest of Europe: Europe Antibiotics Market Breakdown, by Action Mechanism

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Europe Antibiotics Market Industry Landscape

11.1 Overview

11.2 Mergers and Acquisitions

11.3 Agreements, Collaborations, and Joint Ventures

11.4 New Product Launches

11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 GlaxoSmithKline plc

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Sanofi

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Novartis AG

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Bayer AG

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Pfizer Inc

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

13. Appendix

13.1 About Business Market Insights